Back to top
Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets
Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets
Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets
Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets
Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets
Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets

Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets

Price 262.0 INR/ Piece

MOQ : 1 Piece

Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets Specification

  • Salt Composition
  • Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets
  • Life Span
  • 24 Months
  • Origin of Medicine
  • India
  • Packaging Type
  • Blister Pack
  • Brand Name
  • DAPAVILDA MET 10/100/1000
  • Pacakaging (Quantity Per Box)
  • 4x15
  • Drug Type
  • Other
  • Ingredients
  • DAPAVILDA MET 10/100/1000 is an advanced triple-combination oral antidiabetic medicine containing Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg. It is prescribed for the management of Type 2 Diabetes Mellitus in adults when diet, exercise, and single or dual-drug therapy are insufficient to achieve optimal blood glucose control. This combination provides three complementary mechanisms of action. Dapagliflozin helps remove excess glucose through urine, Vildagliptin SR improves insulin secretion and reduces glucagon levels, while Metformin SR decreases glucose production in the liver and enhances insulin sensitivity. The sustained-release (SR) formulation ensures prolonged therapeutic action and better patient compliance. When used alongside a healthy lifestyle, DAPAVILDA MET 10/100/1000 helps maintain blood sugar levels and lowers the risk of diabetes-related complications. Uses DAPAVILDA MET 10/100/1000 is indicated for: Management of Type 2 Diabetes Mellitus in adults Improving glycemic control along with diet and exercise Reducing elevated fasting and post-meal blood glucose levels Supporting long-term diabetes management Helping reduce the risk of diabetes-related complications through effective glucose control Benefits DAPAVILDA MET 10/100/1000 provides comprehensive blood sugar management through triple-action therapy. Effectively lowers blood glucose levels Improves insulin secretion in response to meals Reduces glucose production by the liver Enhances insulin sensitivity in body tissues Promotes urinary excretion of excess glucose Sustained-release formulation provides prolonged glucose control Supports healthy body weight when combined with lifestyle modifications Helps improve HbA1c levels over time Reduces the risk of long-term diabetic complications affecting the heart, kidneys, nerves, and eyes Dosage Take DAPAVILDA MET 10/100/1000 exactly as prescribed by your healthcare provider. The tablet is usually taken once daily with food to minimize stomach discomfort. Swallow the sustained-release tablet whole with water without crushing, chewing, or breaking it. The dosage depends on your blood sugar levels, kidney function, and overall response to treatment. Continue following your recommended diabetic diet, regular exercise program, and blood glucose monitoring schedule. Do not discontinue the medication without consulting your physician. Side Effects Like all medicines, DAPAVILDA MET 10/100/1000 may cause side effects, although not everyone experiences them. Common side effects include: Frequent urination Increased thirst Nausea Diarrhea Stomach discomfort Headache Dizziness Genital fungal infections Urinary tract infections Seek immediate medical attention if you experience symptoms of lactic acidosis, severe allergic reactions, pancreatitis, dehydration, or signs of diabetic ketoacidosis. Precautions and Warnings Before taking DAPAVILDA MET 10/100/1000, inform your doctor if you have kidney disease, liver disease, heart failure, pancreatitis, recurrent urinary tract infections, or dehydration. Regular monitoring of kidney function and blood glucose is recommended during treatment. Maintain adequate hydration, as Dapagliflozin may increase urine output. Avoid excessive alcohol consumption because it may increase the risk of lactic acidosis with Metformin. Pregnant and breastfeeding women should use this medicine only if recommended by their healthcare provider. Inform your doctor about all prescription medicines, over-the-counter drugs, and herbal supplements to avoid potential drug interactions. Conclusion DAPAVILDA MET 10/100/1000 (Dapagliflozin 10 mg, Vildagliptin SR 100 mg & Metformin SR 1000 mg Tablets) is an effective triple-combination therapy for adults with Type 2 Diabetes Mellitus requiring comprehensive blood sugar control. By combining three complementary antidiabetic agents, it helps improve glycemic control, reduce HbA1c levels, enhance insulin function, and lower the risk of long-term diabetes complications. When taken as prescribed and combined with a healthy diet, regular physical activity, and routine medical follow-up, DAPAVILDA MET 10/100/1000 supports better diabetes management and improves overall quality of life.
  • Physical Form
  • Tablets
  • Function
  • Other
  • Recommended For
  • Adults
  • Dosage
  • 10/100/1000
  • Suitable For
  • Suitable For All
  • Quantity
  • 15 Tablets Unit
 

Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets Trade Information

  • Minimum Order Quantity
  • 1 Piece
  • Delivery Time
  • 4 Days
 

Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 1000 mg Tablets About

DAPAVILDA MET 10/100/1000 is an advanced triple-combination oral antidiabetic medicine containing Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 1000 mg. It is prescribed for the management of Type 2 Diabetes Mellitus in adults when diet, exercise, and single or dual-drug therapy are insufficient to achieve optimal blood glucose control. This combination provides three complementary mechanisms of action. Dapagliflozin helps remove excess glucose through urine, Vildagliptin SR improves insulin secretion and reduces glucagon levels, while Metformin SR decreases glucose production in the liver and enhances insulin sensitivity. The sustained-release (SR) formulation ensures prolonged therapeutic action and better patient compliance. When used alongside a healthy lifestyle, DAPAVILDA MET 10/100/1000 helps maintain blood sugar levels and lowers the risk of diabetes-related complications.

Uses

DAPAVILDA MET 10/100/1000 is indicated for:

  • Management of Type 2 Diabetes Mellitus in adults
  • Improving glycemic control along with diet and exercise
  • Reducing elevated fasting and post-meal blood glucose levels
  • Supporting long-term diabetes management
  • Helping reduce the risk of diabetes-related complications through effective glucose control

Benefits

DAPAVILDA MET 10/100/1000 provides comprehensive blood sugar management through triple-action therapy.

  • Effectively lowers blood glucose levels
  • Improves insulin secretion in response to meals
  • Reduces glucose production by the liver
  • Enhances insulin sensitivity in body tissues
  • Promotes urinary excretion of excess glucose
  • Sustained-release formulation provides prolonged glucose control
  • Supports healthy body weight when combined with lifestyle modifications
  • Helps improve HbA1c levels over time
  • Reduces the risk of long-term diabetic complications affecting the heart, kidneys, nerves, and eyes

Dosage

Take DAPAVILDA MET 10/100/1000 exactly as prescribed by your healthcare provider. The tablet is usually taken once daily with food to minimize stomach discomfort. Swallow the sustained-release tablet whole with water without crushing, chewing, or breaking it. The dosage depends on your blood sugar levels, kidney function, and overall response to treatment. Continue following your recommended diabetic diet, regular exercise program, and blood glucose monitoring schedule. Do not discontinue the medication without consulting your physician.

Side Effects

Like all medicines, DAPAVILDA MET 10/100/1000 may cause side effects, although not everyone experiences them.

Common side effects include:

  • Frequent urination
  • Increased thirst
  • Nausea
  • Diarrhea
  • Stomach discomfort
  • Headache
  • Dizziness
  • Genital fungal infections
  • Urinary tract infections

Seek immediate medical attention if you experience symptoms of lactic acidosis, severe allergic reactions, pancreatitis, dehydration, or signs of diabetic ketoacidosis.

Precautions and Warnings

Before taking DAPAVILDA MET 10/100/1000, inform your doctor if you have kidney disease, liver disease, heart failure, pancreatitis, recurrent urinary tract infections, or dehydration. Regular monitoring of kidney function and blood glucose is recommended during treatment. Maintain adequate hydration, as Dapagliflozin may increase urine output. Avoid excessive alcohol consumption because it may increase the risk of lactic acidosis with Metformin. Pregnant and breastfeeding women should use this medicine only if recommended by their healthcare provider. Inform your doctor about all prescription medicines, over-the-counter drugs, and herbal supplements to avoid potential drug interactions.

Conclusion

DAPAVILDA MET 10/100/1000 (Dapagliflozin 10 mg, Vildagliptin SR 100 mg & Metformin SR 1000 mg Tablets) is an effective triple-combination therapy for adults with Type 2 Diabetes Mellitus requiring comprehensive blood sugar control. By combining three complementary antidiabetic agents, it helps improve glycemic control, reduce HbA1c levels, enhance insulin function, and lower the risk of long-term diabetes complications. When taken as prescribed and combined with a healthy diet, regular physical activity, and routine medical follow-up, DAPAVILDA MET 10/100/1000 supports better diabetes management and improves overall quality of life.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Diabetic Range Category

Metformin Hydrochloride Prolonged-release 850 mg and Glimepiride IP 3 mg Tablets

Metformin Hydrochloride Prolonged-release 850 mg and Glimepiride IP 3 mg Tablets

Price 70.0 INR / Unit

Minimum Order Quantity : 1 Unit

Physical Form : Tablets

Dosage Guidelines : Take with food, swallow whole without crushing or chewing. Follow doctor s advice strictly.

Origin of Medicine : INDIA

Storage Instructions : Store in a cool, dry place below 25 C. Protect from moisture and direct sunlight.

Glimepiride & Metformin Hydrochloride Prolonged Release

Glimepiride & Metformin Hydrochloride Prolonged Release

Price 115 INR / Strip

Minimum Order Quantity : 1 Strip

Physical Form : Tablets

Dosage Guidelines : Direction by physician

Origin of Medicine : India

Storage Instructions : Cool and dry place

Metformin (500mg) & Linagliptin (2.5mg)

Metformin (500mg) & Linagliptin (2.5mg)

Price 150.0 INR

Minimum Order Quantity : 100 Pieces

Physical Form : Tablets

Dosage Guidelines : Direction by physician

Origin of Medicine : India

Storage Instructions : Cool and dry place

Glimepiride   Metformin Hydrochloride

Glimepiride Metformin Hydrochloride

Price 55.00 INR / Piece

Minimum Order Quantity : 1 Piece

Physical Form : Tablets

Dosage Guidelines : As Suggested

Origin of Medicine : India